Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.

Shang G, Seed CR, Wang F, Nie D, Farrugia A.

Transfusion. 2007 Mar;47(3):529-39.

PMID:
17319836
2.

Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?

Busch MP.

Transfus Clin Biol. 2004 Feb;11(1):26-32. Review.

PMID:
14980546
3.
4.

[Viruses and unconventional transmissible agents: update on transmission via blood ].

Barin F.

Transfus Clin Biol. 2000 Jun;7 Suppl 1:5s-10s. Review. French.

PMID:
10919217
5.

Hepatitis B virus blood screening: unfinished agendas.

Comanor L, Holland P.

Vox Sang. 2006 Jul;91(1):1-12. Review. Erratum in: Vox Sang. 2007 Apr;92(3):278.

PMID:
16756595
6.

[Controlled viral risks].

Barin F.

Transfus Clin Biol. 2000 Feb;7(1):24-9. Review. French.

PMID:
10730343
7.

Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.

Dwyre DM, Fernando LP, Holland PV.

Vox Sang. 2011 Jan;100(1):92-8. doi: 10.1111/j.1423-0410.2010.01426.x. Review.

PMID:
21175659
8.

Post-transfusion hepatitis: current risks and causes.

Holland PV.

Vox Sang. 1998;74 Suppl 2:135-41. Review.

PMID:
9704436
9.

Tissue donation and virus safety: more nucleic acid amplification testing is needed.

Pruss A, Caspari G, Krüger DH, Blümel J, Nübling CM, Gürtler L, Gerlich WH.

Transpl Infect Dis. 2010 Oct;12(5):375-86. doi: 10.1111/j.1399-3062.2010.00505.x. Review.

PMID:
20412535
10.

The risk of transfusion-transmitted infections in sub-Saharan Africa.

Jayaraman S, Chalabi Z, Perel P, Guerriero C, Roberts I.

Transfusion. 2010 Feb;50(2):433-42. doi: 10.1111/j.1537-2995.2009.002402.x. Epub 2009 Oct 15. Review.

PMID:
19843290
11.

Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT.

Liu CJ, Chen DS, Chen PJ.

J Clin Virol. 2006 May;36 Suppl 1:S33-44. Review.

PMID:
16831692
12.

Overview: diagnostic tests for viral infections transmitted by blood.

Holland PV.

Nucl Med Biol. 1994 Apr;21(3):407-17. Review.

PMID:
9234305
13.

[Screening for viral genomes in blood transfusion].

Coste J.

Transfus Clin Biol. 2000 Jun;7 Suppl 1:11s-17s. Review. French.

PMID:
10919218
14.

Hepatitis C virus and blood transfusion: past and present risks.

van der Poel CL.

J Hepatol. 1999;31 Suppl 1:101-6. Review.

PMID:
10622570
15.

Screening of HIV infection: role of molecular and immunological assays.

Weber B.

Expert Rev Mol Diagn. 2006 May;6(3):399-411. Review.

PMID:
16706742
16.

Nucleic acid testing (NAT) in high prevalence-low resource settings.

El Ekiaby M, Lelie N, Allain JP.

Biologicals. 2010 Jan;38(1):59-64. doi: 10.1016/j.biologicals.2009.10.015. Epub 2010 Jan 15. Review.

PMID:
20079664
17.

Nucleic acid testing for transfusion-transmissible agents.

Stramer SL.

Curr Opin Hematol. 2000 Nov;7(6):387-91. Review.

PMID:
11055512
18.

[Technological evolutions in blood donation screening and their impact on the residual risk].

Barlet V.

Transfus Clin Biol. 2011 Apr;18(2):292-301. doi: 10.1016/j.tracli.2011.02.025. Epub 2011 Apr 3. Review. French.

PMID:
21466969
19.

Yield and future issues of nucleic acid testing.

Roth WK, Seifried E.

Transfus Clin Biol. 2001 Jun;8(3):282-4. Review.

PMID:
11499978
20.

Genomic screening for blood-borne viruses in transfusion settings.

Allain JP.

Clin Lab Haematol. 2000 Feb;22(1):1-10. Review.

PMID:
10762297
Items per page

Supplemental Content

Write to the Help Desk